New study tracks hemophilia a risks across generations
NCT ID NCT07414511
First seen Feb 22, 2026 · Last updated Jun 23, 2026 · Updated 16 times
Summary
This study follows 500 mother-child pairs where the mother has a severe hemophilia A gene. Researchers want to learn why some mothers have heavy bleeding after childbirth and why some children develop antibodies to factor VIII treatment. By observing families over time, the study aims to uncover genetic and environmental factors that influence these risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Washington
RECRUITINGSeattle, Washington, 98109, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could improve care for pregnant women with hemophilia A and help predict which children will develop antibodies to treatment.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test any new therapy, and results may take years to influence clinical practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.